Cleartronic, Inc. (CLRI) Subsidiary VoiceInterop Signs Definitive Agreement Acquiring the Assets of CanniPlus Global, Inc.
SUBSIDIARY VOICEINTEROP, INC. TO BE SPUN OFF IN A FORM 10 AND S-1 REGISTRATION WITH THE SECURITIES AND EXCHANGE COMMISSION
BOCA RATON, Fla., April 24, 2018 (GLOBE NEWSWIRE) -- Cleartronic, Inc., (OTCPINK:CLRI) announced today its subsidiary VoiceInterop, Inc. have signed a “Definitive Agreement” for the acquisition of the assets and intellectual property of CanniPlus Global, Inc., a Florida based medical CBD company.
The closing of the Asset Purchase Agreement is conditioned on VoiceInterop’s business being spun-off from Cleartronic in the second or third quarter of fiscal 2018. VoiceInterop will file a Form S-1 registration statement with the SEC to register the shares being distributed to Cleartronic shareholders and the shares being issued to the shareholders of Canopus Global, Inc. VoiceInterop also intends to register its common stock under the Exchange Act.
Larry Reid, President of VoiceInterop stated, “We are extremely excited to enter the medical Cannabidiol (“CBD”) marketplace. Numerous studies and recent news articles show that CBD use is increasing worldwide and the timing of our entry into this market space could not be better.”
“Prior to our acquisition of the assets and IP, CanniPlus launched a new line of CBD products. In addition, CanniPlus signed exclusive consulting and distribution agreements with Florida based Medical Marijuana Consulting Group (”MMCG”) and HL Medical, Inc.” said Reid. “MMCG has five retail locations in South Florida where they assist with the application process for clients seeking a State of Florida Medical Marijuana Card. HL Medical is a network of 20 clinics and 109 certified and experienced medical marijuana physicians in the State of Florida.”
Reid continued, “Our exclusive agreements with MMCG and HL Medical will provide consulting services and an immediate vertical distribution channel for our line of CBD tinctures, edibles and topicals. Studies suggest that CBDs may lead to relief of pain, stress and anxiety. Our HL Medical Doctor network will provide clients with evaluations and recommendations on the use of our CBD products.”
Reid closed by stating, “At 12 noon on Tuesday, April 24th, 2018, I will be appearing LIVE in studio on 740 AM, 103.9 FM and 96.9 FM to discuss the CanniPlus Transaction. I will be interviewed by long time radio show host Mick Bazsuly. His show will be broadcast all around South Florida as well as worldwide on www.wsbradio.com and filmed on AMP2.TV. Questions may be submitted prior to the show to firstname.lastname@example.org and will be asked on air. The show will be viewable at www.youtube.com under the Mick Bazsuly Show.”
Cannabidiol, also known as CBD is found throughout the seeds, stalk and flowers of cannabis plants including hemp and marijuana. Because of the numerous medical benefits, people are continually seeking CBD products, creating a high growth market in cannabidiol consumption.
About Cleartronic, Inc.
Cleartronic, Inc., a diversified holding Company, creates and acquires operating subsidiaries with the goal of manufacturing and selling products, services, and integrated systems to government agencies, business enterprises and the general public. In addition to its ongoing research and development projects, Cleartronic currently has two operating subsidiaries, ReadyOp Communications, Inc. and VoiceInterop, Inc.- www.cleartronic.com, www.voiceinterop.com and www.readyop.com.
About VoiceInterop/Canniplus Global, Inc.
CanniPlus Global is a Medical CBD Company focused on improving and preserving the health of people using the benefits and medicinal qualities of the Cannabis sativa plant. We take into account the needs of those looking for an alternative to traditional medicine by providing high-quality products extracted from Cannabis sativa plants. Canniplus Global owns the exclusive licensing and grow production rights of CanniPlus Colombia SAS. www.canniplus.com
Safe Harbor Statement
This news release contains statements that involve expectations, plans or intentions (such as those relating to future business or financial results) and other factors discussed from time to time in the Cleartronic’s Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. You can identify these forward-looking statements by words such as "may," "should," "expect," "anticipate," "believe," "estimate," "intend," "plan" and other similar expressions. Our actual results could differ materially from those anticipated in these forward-looking statements because of certain factors not within the control of the company. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to Cleartronic and VoiceInterop’s ability to finalize and enter into definitive agreements with strategic partners, VoiceInterop’s ability to have its registration statement on Form S-1 declared effective by the SEC, VoiceInterop and Cleartronic’s ability to close the acquisition of CanniPlus Global, the availability of additional funding, the early-stage nature of the industry sector; regulatory changes affecting the sale, transport or consumption of Cannabidiol or hemp based products by humans or animals, commercial impacts to the Company’s business, related agreements, product development, marketing and distribution plans and strategies. Cleartronic cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Cleartronic disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
Contact and Inquiries for Investor Relations:
561-939-3300 Ext 143